How AI and Robotics Are Changing Orthopedic Surgery

A decade ago, robotic-assisted surgery in orthopedics was a novelty. A handful of academic medical centers had systems. Most community orthopedic surgeons had never touched one. The technology was expensive, the learning curves were steep, and the clinical evidence was thin enough that skeptics had plenty of room to push back.

That era is over. As of 2026, robotic-assisted platforms are installed in thousands of facilities across the United States. AI-powered preoperative planning software is becoming standard workflow in joint replacement and spine. Machine learning algorithms are being used to predict implant sizing, patient outcomes, and even complication risk before the first incision. The question is no longer whether AI and robotics will change orthopedic surgery. The question is how fast, and what it means for everyone in the supply chain — including the device reps standing in the OR.

This article breaks down what’s actually happening with AI and robotics in orthopedic surgery right now, where the technology is headed, and what independent medical device sales professionals need to understand to stay relevant in a market that is being reshaped in real time.

The Current State of Robotics in Orthopedic Surgery

Robotic-assisted orthopedic surgery is not one technology. It is a category that includes several distinct platforms, each with different capabilities, surgical applications, and market positioning. Understanding the differences matters if you sell into this space.

The Major Platforms

Stryker Mako. The market leader in robotic-assisted joint replacement. Mako uses CT-based 3D modeling to create a patient-specific surgical plan, then provides haptic-guided boundaries during surgery that physically resist the surgeon’s hand if the saw or burr moves outside the planned bone cuts. It is FDA-cleared for total knee, partial knee, and total hip arthroplasty. Stryker has placed thousands of Mako units in U.S. facilities, and the install base continues to grow.

Zimmer Biomet ROSA. The ROSA platform covers knee replacement and spine procedures. For knee, ROSA uses an optical tracking system and does not require preoperative CT scans — it can work from standard X-rays with intraoperative bone mapping. For spine, ROSA provides guided pedicle screw placement. Zimmer Biomet has been aggressive about expanding ROSA’s footprint, particularly in community hospitals and ASCs where the CT-free workflow appeals to facilities concerned about preoperative imaging costs and scheduling.

Smith+Nephew CORI. The CORI system is a handheld robotic platform for knee replacement that uses intraoperative data collection rather than preoperative CT. It is smaller and more portable than the Mako, which makes it attractive for ambulatory surgery centers with limited OR space. Smith+Nephew has positioned CORI as a lower-barrier entry point for surgeons who want robotic assistance without the capital commitment and workflow changes of a full robotic system.

Globus Medical ExcelsiusGPS. Focused primarily on spine, the ExcelsiusGPS is a robotic navigation platform for screw placement in spinal fusion procedures. It uses a rigid robotic arm to guide instrumentation along a planned trajectory, reducing the need for fluoroscopy and improving screw accuracy. Since Globus merged with NuVasive, the combined entity has been pushing ExcelsiusGPS as a differentiator in the spine market.

Medtronic Mazor X Stealth Edition. Medtronic’s spine robotics platform integrates the Mazor robotic guidance system with Stealth navigation. It provides preoperative 3D planning with intraoperative robotic guidance for pedicle screw placement. Medtronic’s install base is significant, and the integration with their broader spine implant portfolio gives them a bundled sales approach.

Adoption Numbers

Exact adoption figures are proprietary, but the trajectory is clear. Industry estimates suggest that robotic-assisted procedures now account for roughly 15-20% of all total knee replacements performed in the United States, up from single digits five years ago. In spine, robotic-guided screw placement is growing rapidly, particularly for complex deformity cases and minimally invasive procedures where accuracy is critical and fluoroscopy time needs to be minimized.

The adoption curve is not uniform. Large academic medical centers and high-volume orthopedic specialty hospitals adopted early. Community hospitals are in the middle wave now. ASCs are the next frontier, and the platforms are getting smaller and more portable specifically to serve that market segment.

AI-Powered Preoperative Planning

If robotics is the hardware story, AI-powered preoperative planning is the software story — and in many ways, it is the more significant development for day-to-day surgical practice.

Traditional preoperative planning for joint replacement involved the surgeon templating implant sizes on 2D X-rays, estimating bone cuts based on anatomical landmarks, and making final adjustments intraoperatively based on feel and experience. It worked. Surgeons with thousands of cases under their belt became very good at it. But it was inherently imprecise, and the quality of the plan depended entirely on the individual surgeon’s skill and experience.

AI-powered planning changes this in several ways:

• Automated CT segmentation. AI algorithms can take a preoperative CT scan and automatically segment the bone anatomy, identifying the joint surfaces, axes of rotation, and anatomical landmarks in minutes rather than the hours it would take a human to do manually. This creates a precise 3D model of the patient’s actual anatomy.
• Implant sizing prediction. Machine learning models trained on thousands of previous cases can predict the optimal implant size and position with high accuracy. The surgeon still makes the final decision, but they start with a data-driven recommendation rather than a best guess from a 2D template.
• Alignment optimization. AI planning software can model different alignment strategies — mechanical axis, kinematic alignment, restricted kinematic alignment — and show the surgeon how each approach would look on the patient’s specific anatomy before they make a single cut.
• Bone preservation modeling. The software can calculate exactly how much bone will be removed with different implant positions and sizes, allowing surgeons to optimize for bone preservation, which matters for younger patients who may need revision surgery decades later.

The practical impact is that surgeons walk into the OR with a specific, patient-matched surgical plan rather than a general approach they adjust on the fly. This is especially valuable for less experienced surgeons, but even high-volume surgeons report that AI-assisted planning catches anatomical variations they might have missed on traditional imaging.

Robotic-Assisted Joint Replacement: What’s Changed

Joint replacement is where robotic-assisted surgery has made the deepest penetration, and total knee arthroplasty is the specific procedure driving most of the volume.

Why Knees More Than Hips

The knee is a more complex joint to replace than the hip from an alignment and balancing perspective. In hip replacement, the primary goals are restoring leg length, offset, and acetabular cup positioning. These are important, but the hip joint is inherently more forgiving than the knee. A total knee replacement requires precise bone cuts on the femur and tibia, accurate implant rotation, proper ligament balancing through the full range of motion, and alignment decisions that affect the patient’s ability to walk, climb stairs, and kneel for the rest of their life.

This complexity is exactly where robotic assistance adds the most value. The technology provides sub-millimeter accuracy in bone preparation, real-time feedback on gap balancing, and the ability to make micro-adjustments before committing to a final implant position.

The Clinical Evidence

The published data on robotic-assisted total knee replacement is now substantial enough to draw some conclusions:

• Accuracy. Robotic-assisted TKA consistently achieves the planned alignment with tighter tolerances than manual techniques. Multiple studies show fewer outliers — patients who end up with alignment significantly different from what the surgeon intended.
• Short-term outcomes. Some studies show faster recovery, less pain, and better early range of motion with robotic-assisted TKA. The effect sizes are modest, and not all studies agree.
• Long-term survivorship. This is the data everyone wants, and it does not fully exist yet. Robotic-assisted TKA at high volume is still relatively new. The 10 and 15-year implant survivorship data that would definitively answer whether better alignment translates to longer-lasting implants is still being collected.
• Cost-effectiveness. This is where the picture gets complicated. Robotic systems have significant capital costs ($1-2 million+ for the platform, plus per-case disposable costs). The break-even calculation depends on case volume, reimbursement rates, marketing value, and whether you count reduced revision rates as a savings — a revision that happens 12 years from now at a different facility does not directly save money for the facility that bought the robot.

The Surgeon Adoption Curve

Surgeon uptake falls into predictable categories. Early adopters were technology-forward academic surgeons and high-volume arthroplasty specialists who wanted to push the precision envelope. The current wave is community orthopedic surgeons who are seeing their patients ask about robotic surgery and their competitors market it. The holdouts are experienced surgeons with excellent manual results who see the technology as an expensive solution to a problem they have already solved with their own hands.

That last group is shrinking, but it still exists. And they are not wrong that a highly experienced surgeon with excellent manual technique can achieve great results without a robot. The technology’s biggest impact may ultimately be in narrowing the quality gap between average and excellent surgeons rather than making excellent surgeons better.

Robotics in Spine Surgery

Spine surgery presents a different set of problems than joint replacement, and robotic technology addresses them differently.

The primary use case for robotics in spine is pedicle screw placement. Pedicle screws are the anchor points for spinal fusion constructs — they are placed into the vertebral bodies and connected by rods to stabilize a segment of the spine. Accurate screw placement is critical because the pedicle (the bony channel through which the screw passes) is surrounded by neural elements. A misplaced screw can cause nerve damage, vascular injury, or inadequate fixation that leads to construct failure.

Traditionally, pedicle screws are placed using fluoroscopy (real-time X-ray) and the surgeon’s anatomical knowledge. Experienced spine surgeons achieve excellent accuracy rates with freehand technique, but the procedure requires significant fluoroscopy time — exposing the surgeon, staff, and patient to radiation — and the accuracy rates drop in challenging anatomy like scoliotic or osteoporotic spines.

Robotic guidance for pedicle screw placement works by creating a preoperative plan based on CT imaging, then using a robotic arm to guide the surgeon’s instruments along the planned trajectory. The clinical evidence consistently shows:

• Higher screw placement accuracy compared to fluoroscopy-guided freehand technique
• Significantly reduced radiation exposure for the surgical team
• Particular benefit in revision surgery, deformity cases, and minimally invasive approaches where traditional landmarks are obscured or distorted
• Faster screw placement times once the surgeon is past the learning curve

Spine robotics is also evolving beyond just screw placement. Newer applications include robotic-assisted interbody cage placement, endoscopic decompression guidance, and integration with intraoperative imaging like O-arm CT to provide real-time verification of implant position without opening the patient further.

AI and Predictive Analytics in Patient Outcomes

Beyond the operating room, AI is being applied to orthopedic care in ways that have less immediate visibility but potentially enormous long-term impact.

Outcome Prediction Models

Machine learning models are being trained on large datasets of patient demographics, imaging, comorbidities, and surgical variables to predict individual patient outcomes after orthopedic procedures. These models can estimate, before surgery, the likelihood that a specific patient will achieve a meaningful improvement in pain and function after a total knee replacement. This has implications for patient selection, expectation management, and even insurance authorization.

Complication Risk Stratification

AI models are being developed to predict which patients are at elevated risk for specific complications — surgical site infection, venous thromboembolism, readmission, revision surgery. The goal is to allow the surgical team to implement targeted prevention protocols for high-risk patients rather than applying the same blanket prophylaxis to everyone.

Implant Wear and Failure Prediction

AI analysis of follow-up imaging can detect early signs of implant loosening, polyethylene wear, or osteolysis before the patient becomes symptomatic. Catching a failing implant early allows for planned revision surgery rather than emergency intervention after a catastrophic failure.

Post-Operative Monitoring

Wearable sensors and remote monitoring platforms are generating continuous data streams on patient activity, gait patterns, and range of motion after orthopedic surgery. AI algorithms process this data to identify patients who are falling behind expected recovery trajectories, triggering early intervention from the care team. This is particularly relevant for total joint replacement patients, where early mobilization and rehab compliance significantly affect long-term outcomes.

What This Means for Medical Device Reps

Here is the part that matters most if you sell orthopedic devices for a living. AI and robotics are changing your job. Not eliminating it — the demand for knowledgeable reps in the OR is actually increasing with these technologies — but changing what you need to know, what you need to do, and how you add value.

Technical Knowledge Requirements Are Rising

If your surgeon is using a robotic platform, you need to understand that platform at a deep level. Not just how to turn it on. You need to understand the preoperative planning workflow, the registration process, the intraoperative display, the error messages, the troubleshooting protocols, and the fallback plan when the technology fails mid-case. Because it will fail occasionally, and when it does, the surgeon needs their rep to either fix it or seamlessly transition to a manual approach without losing time.

This is a significant training investment. Reps who carry orthopedic surgical implants paired with robotic platforms need certification on the specific system, and the certification programs are not trivial. But this training creates a real barrier to entry that protects your position once you have it.

Your Role in the OR Is Evolving

In a manual case, the rep’s primary OR value is having the right implants on the back table and being available to answer the surgeon’s questions about sizing, instrumentation, and technique. In a robotic-assisted case, the rep’s role expands to include technology management. You are managing the planning software, assisting with patient registration, monitoring the system during bone preparation, and potentially troubleshooting hardware or software issues in real time.

This expanded role means you are more embedded in the surgical workflow, harder to replace, and more valuable to the surgeon. That is the upside. The downside is that it takes more time per case, more training, and more cognitive load.

Capital Sales Create Pull-Through

Robotic platforms are capital equipment tied to specific implant systems. A hospital that installs a Mako is going to use Stryker knee and hip implants for every case done on that platform. A facility with ExcelsiusGPS is going to use Globus/NuVasive spine hardware. The capital placement creates years of implant pull-through that benefits the rep covering those cases.

For independent reps and distributors, this dynamic cuts both ways. If you carry the right product lines aligned with the installed robotic platform, you have a locked-in revenue stream. If the facility installs a competitor’s robot, you may lose access to those cases entirely. Understanding which platforms are being evaluated at your accounts is critical competitive intelligence.

Selling Has Changed

Surgeons who use robotic platforms make implant decisions differently. The planning software shows them exactly how a specific implant design will fit their patient’s anatomy. This means they are evaluating implants based on 3D fit modeling, not just catalog specs and cadaver lab impressions. Reps need to understand how their hardware performs in the planning software and be prepared to discuss implant design features in the context of patient-specific anatomy.

The Limitations Nobody Talks About

The vendor marketing around surgical robotics is relentlessly positive. Here is what the glossy brochures leave out.

Cost Is Still a Problem

Robotic platforms cost $1-2.5 million to purchase, with annual maintenance contracts running $100,000-$200,000. Per-case disposable costs add $500-$2,000 to every procedure. For high-volume facilities doing 400+ joints per year, the per-case cost is manageable. For a community hospital doing 150 joints annually, the math is difficult without significant implant price concessions from the manufacturer — which they are often willing to make because the capital placement locks in years of implant revenue.

Learning Curves Are Real

Every robotic platform has a learning curve. Published data suggests 20-40 cases before most surgeons are comfortable and efficient with robotic-assisted TKA. During the learning curve, case times are longer, and the complication risk may actually be higher than the surgeon’s baseline manual technique. This is not a technology you can demo once and start using the next day.

The Technology Can Fail

Software crashes, registration errors, optical tracking interference, hardware malfunctions — all of these happen. When a robotic system fails mid-case, the surgeon needs to convert to a manual technique, which means every surgeon using robotic assistance needs to maintain their manual skills as a backup. The rep needs to have manual instrumentation available and know how to facilitate a seamless conversion.

Better Alignment May Not Mean Better Outcomes

The fundamental premise of robotic-assisted surgery is that more precise bone preparation and implant positioning leads to better patient outcomes. This is logical, and there is supporting evidence. But the effect size is smaller than the marketing implies, and other factors — soft tissue balancing, patient selection, rehabilitation compliance, pain management — may matter as much or more than the precision of the bone cuts.

Where This Is Headed

Several trends are clear:

• Platforms will get smaller and cheaper. The economics need to work for ASCs and smaller facilities. Expect handheld and semi-autonomous systems that cost a fraction of current full robotic platforms.
• AI planning will become standard. Within five years, AI-assisted preoperative planning will likely be the default workflow for joint replacement, not the exception. Surgeons who template on 2D X-rays will be outliers.
• Data feedback loops will improve implant design. AI analysis of outcomes data linked to specific implant designs, sizes, and positioning will feed back into product development, creating implants optimized by machine learning rather than just engineering intuition.
• Autonomous and semi-autonomous functions will expand. Today, the surgeon controls every movement with robotic guidance providing boundaries. Tomorrow, specific surgical steps — bone preparation in total knee, screw trajectory in spine — may be performed autonomously by the robot with surgeon oversight. This is technically possible now but faces significant regulatory and liability hurdles.
• Mixed reality integration. AR headsets displaying patient anatomy, surgical plans, and implant positioning overlaid on the actual surgical field are in development. This could eventually complement or partially replace traditional robotic arms.

For medical device sales professionals and distributors, the bottom line is this: AI and robotics are not a side trend in orthopedics. They are becoming the core delivery mechanism for surgical care. Your ability to support these technologies, sell around them, and help your surgeons get the most out of them will determine your relevance and your income over the next decade.

Frequently Asked Questions

Will AI and robotics replace medical device sales reps in the operating room?

No. Robotic-assisted surgery actually increases the need for knowledgeable reps in the OR, not decreases it. Someone has to manage the technology, troubleshoot problems, assist with preoperative planning, and ensure the right implants and instrumentation are available for each case. The role is changing — reps need to understand both the implants and the technology platforms — but the demand for skilled in-OR support is growing. What will be replaced is the rep who shows up with a tray, stands in the corner, and adds no technical value.

Do surgeons have to use robotic systems to be competitive?

Not yet, but the pressure is increasing. Patients are asking about robotic surgery after seeing marketing from hospitals and direct-to-consumer advertising from device companies. Surgeons in competitive markets are adopting robotic platforms partly for clinical reasons and partly because their competitors have them and are marketing accordingly. A highly skilled surgeon with excellent manual technique can still achieve outstanding results without a robot. But market forces are pushing adoption regardless of whether the clinical difference justifies the cost.

How should independent device reps prepare for the shift toward robotic surgery?

First, understand which robotic platforms are installed or being evaluated at every facility in your territory. Second, get certified on the platforms that align with the product lines you carry. Third, invest time in understanding AI-powered preoperative planning software — even if your primary products are not robotic, the planning workflows affect how surgeons evaluate and select implants. Finally, position yourself as the rep who can support the full technology stack, not just the hardware. The reps who thrive in a robotic-assisted market are the ones who reduce complexity for the surgeon and the facility, and that requires technical knowledge beyond product specifications.

What does robotic surgery mean for ambulatory surgery centers?

ASCs are a major growth market for robotic-assisted orthopedic surgery. As total joint procedures move to outpatient settings, ASCs need technology that supports efficient, high-quality surgical workflows in a smaller footprint with lower overhead. Robotic platforms designed for ASCs — smaller, more portable, less expensive — are actively being developed and marketed. For device reps and distributors serving ASCs, the ability to support robotic-assisted cases will increasingly be a requirement, not a differentiator.